Heart and Vessels

, Volume 34, Issue 5, pp 735–744 | Cite as

Prognostic significance of renal dysfunction and its change pattern on outcomes in patients with acute coronary syndrome treated with emergent percutaneous coronary intervention

  • Kenichiro OtsukaEmail author
  • Kenei Shimada
  • Hisashi Katayama
  • Haruo Nakamura
  • Hirotoshi Ishikawa
  • Hisateru Takeda
  • Kohei Fujimoto
  • Noriaki Kasayuki
  • Minoru Yoshiyama
Original Article


Renal dysfunction and its change pattern are associated with short- and long-term mortality. However, it remains to be investigated whether or not worsening renal function (WRF) defined by baseline renal function identified from different time points would provide prognostic implication on outcomes in acute coronary syndrome (ACS) patients. This study consists of 334 ACS patients (mean age 68 ± 11 years, 75% male) treated with emergent percutaneous coronary intervention (PCI). Estimated glomerular filtration rate (eGFR) was evaluated on baseline, during hospitalization, at discharge, and at 3-month follow-up. WRF was defined as a relative decrease of eGFR > 20% at 3 months using baseline eGFR identified from different time points. The primary end point was a composite event of major cardiovascular events (MACE), including all-cause death, ACS, and heart failure hospitalization. The associations of chronic kidney disease (CKD), acute kidney injury (AKI), and WRF with MACE were evaluated. During a mean follow-up of 3.3 ± 1.7 years, a total of 64 MACE were observed. Multivariable analysis revealed that CKD (hazard ratio 2.16; p = 0.018) and AKI (hazard ratio 1.95; p = 0.030) were independent predictors of MACE, but WRF did not remain as an independent predictor of MACE (p = 0.208). The highest risk was observed in AKI patients with CKD when stratified by the presence or absence of CKD and AKI. In ACS patients treated with emergent PCI, this study demonstrated that CKD and AKI were independent predictors of MACE, while there was no independent relationship between WRF and MACE.


Acute coronary syndrome Chronic kidney disease Acute kidney injury Worsening renal function Prediction 


Compliance with ethical standards

Conflict of interest

The authors declare no conflict of interest.


  1. 1.
    Anavekar NS, McMurray JJV, Velazquez EJ, Solomon SD, Kober L, Rouleau J-L, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA (2004) Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351:1285–1295CrossRefGoogle Scholar
  2. 2.
    Marenzi G, Cabiati A, Cosentino N, Assanelli E, Milazzo V (2014) Prognostic significance of serum creatinine and its change patterns in patients with acute coronary syndromes. Am Heart J 169:363–370CrossRefGoogle Scholar
  3. 3.
    Watabe H, Sato A, Hoshi T, Takeyasu N, Abe D, Akiyama D, Kakefuda Y, Nishina H, Noguchi Y, Aonuma K (2014) Association of contrast-induced acute kidney injury with long-term cardiovascular events in acute coronary syndrome patients with chronic kidney disease undergoing emergent percutaneous coronary intervention. Int J Cardiol 174:57–63CrossRefGoogle Scholar
  4. 4.
    Marenzi G, Cosentino N, Bartorelli AL (2015) Acute kidney injury in patients with acute coronary syndromes. Heart 101:1778–1785CrossRefGoogle Scholar
  5. 5.
    Matsue Y, Matsumura A, Abe M, Ono M, Seya M, Nakamura T, Iwatsuka R, Mizukami A, Setoguchi M, Nagahori W, Ohno M, Suzuki M, Hashimoto Y (2013) Prognostic implications of chronic kidney disease and anemia after percutaneous coronary intervention in acute myocardial infarction patients. Heart Vessels 28:19–26CrossRefGoogle Scholar
  6. 6.
    Abe D, Sato A, Hoshi T, Kakefuda Y, Watabe H, Ojima E, Hiraya D, Harunari T, Takeyasu N, Aonuma K (2014) Clinical predictors of contrast-induced acute kidney injury in patients undergoing emergency versus elective percutaneous coronary intervention. Circ J 78:85–91CrossRefGoogle Scholar
  7. 7.
    Shacham Y, Leshem-Rubinow E, Gal-Oz A, Arbel Y, Keren G, Roth A, Steinvil A (2015) Acute cardio-renal syndrome as a cause for renal deterioration among myocardial infarction patients treated with primary percutaneous intervention. Can J Cardiol 31:1240–1244CrossRefGoogle Scholar
  8. 8.
    Maioli M, Toso A, Leoncini M, Gallopin M, Musilli N, Bellandi F (2012) Persistent renal damage after contrast-induced acute kidney injury: Incidence, evolution, risk factors, and prognosis. Circulation 125:3099–3107CrossRefGoogle Scholar
  9. 9.
    Coca SG, Singanamala S, Parikh CR (2012) Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 81:442–448CrossRefGoogle Scholar
  10. 10.
    Siew ED, Parr SK, Abdel-Kader K, Eden SK, Peterson JF, Bansal N, Hung AM, Fly J, Speroff T, Ikizler TA, Matheny ME (2016) Predictors of recurrent AKI. J Am Soc Nephrol 27:1190–1200CrossRefGoogle Scholar
  11. 11.
    Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, Arima H, Chadban SJ, Cirillo M, Djurdjev O, Green JA, Heine GH, Inker LA, Irie F, Ishani A, Iiix JH, Kovesdy CP, Marks A, Ohkubo T, Shalev V, Shankar A, Wen CP, de Jong PE, Iseki K, Stengel B, Gansevoort RT, Levey AS (2014) Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 311:2518–2531CrossRefGoogle Scholar
  12. 12.
    Sawhney S, Mitchell M, Marks A, Fluck N, Black C (2015) Long-term prognosis after acute kidney injury (AKI): what is the role of baseline kidney function and recovery? A systematic review. BMJ Open 5:e006497CrossRefGoogle Scholar
  13. 13.
    Ogita M, Sakakura K, Nakamura T, Funayama H, Wada H, Naito R, Sugawara Y, Kubo N, Ako J, Momomura SI (2012) Association between deteriorated renal function and long-term clinical outcomes after percutaneous coronary intervention. Heart Vessels 27:460–467CrossRefGoogle Scholar
  14. 14.
    Nemoto N, Iwasaki M, Nakanishi M, Araki T, Utsunomiya M, Hori M, Ikeda N, Makino K, Itaya H, Iijima R, Hara H, Takagi T, Joki N, Sugi K, Nakamura M (2014) Impact of continuous deterioration of kidney function 6 to 8 months after percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol 113:1647–1651CrossRefGoogle Scholar
  15. 15.
    Damman K, Navis G, Voors AA, Asselbergs FW, Smilde TDJ, Cleland JGF, van Veldhuisen DJ, Hillege HL (2007) Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail 13:599–608CrossRefGoogle Scholar
  16. 16.
    Damman K, Valente MAE, Voors AA, O’Connor CM, Van Veldhuisen DJ, Hillege HL (2014) Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J 35:455–469CrossRefGoogle Scholar
  17. 17.
    Beldhuis IE, Streng KW, Ter Maaten JM, Voors AA, van der Meer P, Rossignol P, McMurray JJV, Damman K (2017) Renin-angiotensin system inhibition, worsening renal function, and outcome in heart failure patients with reduced and preserved ejection FractionCLINICAL PERSPECTIVE. Circ Hear Fail 10:e003588Google Scholar
  18. 18.
    Pannu N, James M, Hemmelgarn B, Klarenbach S (2013) Association between AKI, recovery of renal function, and long-term outcomes after hospital discharge. Clin J Am Soc Nephrol 8:194–202CrossRefGoogle Scholar
  19. 19.
    Kellum JA, Lameire N, Aspelin P, Barsoum RS, Burdmann EA, Goldstein SL, Herzog CA, Joannidis M, Kribben A, Levey AS, MacLeod AM, Mehta RL, Murray PT, Naicker S, Opal SM, Schaefer F, Schetz M, Uchino S (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2:1–138CrossRefGoogle Scholar
  20. 20.
    Wright RS, Anderson JL, Adams CD, Bridges CR, Casey DE, Ettinger SM, Fesmire FM, Ganiats TG, Jneid H, Lincoff AM, Peterson ED, Philippides GJ, Theroux P, Wenger NK, Zidar JP, Jacobs AK (2011) 2011 ACCF/AHA focused update of the guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline): a Report of the American College of Cardiology Foundation/American Heart Association. Circulation 123:2022–2060CrossRefGoogle Scholar
  21. 21.
    Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Ting HH, O’Gara PT, Kushner FG, Ascheim DD, Brindis RG, Casey DE Jr, Chung MK, de Lemos JA, Diercks DB, Fang JC, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX (2016) 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction. J Am Coll Cardiol 67:1235–1250CrossRefGoogle Scholar
  22. 22.
    Jurado-Román A, Hernández-Hernández F, García-Tejada J, Granda-Nistal C, Molina J, Velázquez M, Albarrán A, Tascón J (2015) Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention. Am J Cardiol 115:1174–1178CrossRefGoogle Scholar
  23. 23.
    Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S (2010) Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates. Am J Kidney Dis 56:32–38CrossRefGoogle Scholar
  24. 24.
    Ohsawa M, Tanno K, Itai K, Turin TC, Okamura T, Ogawa A, Ogasawara K, Fujioka T, Onoda T, Yoshida Y, Omama S, Ishibashi Y, Nakamura M, Makita S, Tanaka F, Kuribayashi T, Koyama T, Sakata K, Okayama A (2013) Comparison of predictability of future cardiovascular events between chronic kidney disease (CKD) stage based on CKD epidemiology collaboration equation and that based on modification of diet in renal disease equation in the Japanese general population. Circ J 77:1315–1325CrossRefGoogle Scholar
  25. 25.
    Testani JM, Kimmel SE, Dries DL, Coca SG (2011) Prognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy in patients with cardiac dysfunction. Circ Hear Fail 4:685–691CrossRefGoogle Scholar
  26. 26.
    Rossignol P, Cleland JGF, Bhandari S, Tala S, Gustafsson F, Fay R, Lamiral Z, Dobre D, Pitt B, Zannad F (2012) Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the eplerenone post-acute myocardial infarction heart failure efficacy and survival study. Circulation 125:271–279CrossRefGoogle Scholar
  27. 27.
    Hijazi Z, Hohnloser SH, Andersson U, Alexander JH, Hanna M, Keltai M, Parkhomenko A, López-Sendón JL, Lopes RD, Siegbahn A, Granger CB, Wallentin L (2016) Efficacy and safety of apixaban compared with warfarin in patients with atrial fibrillation in relation to renal function over time: Insights from the Aristotle randomized clinical trial. JAMA Cardiol 1:451–460CrossRefGoogle Scholar
  28. 28.
    Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention. J Am Coll Cardiol 44:1393–1399Google Scholar
  29. 29.
    Giacoppo D, Madhavan MV, Baber U, Warren J, Bansilal S, Witzenbichler B, Dangas GD, Kirtane AJ, Xu K, Kornowski R, Brener SJ, Généreux P, Stone GW, Mehran R (2015) Impact of contrast-induced acute kidney injury after percutaneous coronary intervention on short- and long-term outcomes: pooled analysis from the HORIZONS-AMI and ACUITY trials. Circ Cardiovasc Interv 8:e002475CrossRefGoogle Scholar
  30. 30.
    Yang L, Xing G, Wang L, Wu Y, Li S, Xu G, He Q, Chen J, Chen M, Liu X, Zhu Z, Yang L, Lian X, Ding F, Li Y, Wang H, Wang J, Wang R, Mei C, Xu J, Li R, Cao J, Zhang L, Wang Y, Xu J, Bao B, Liu B, Chen H, Li S, Zha Y, Luo Q, Chen D, Shen Y, Liao Y, Zhang Z, Wang X, Zhang K, Liu L, Mao P, Guo C, Li J, Wang Z, Bai S, Shi S, Wang Y, Wang J, Liu Z, Wang F, Huang D, Wang S, Ge S, Shen Q, Zhang P, Wu L, Pan M, Zou X, Zhu P, Zhao J, Zhou M, Yang L, Hu W, Wang J, Liu B, Zhang T, Han J, Wen T, Zhao M, Wang H (2015) Acute kidney injury in China: a cross-sectional survey. Lancet 386:1465–1471CrossRefGoogle Scholar
  31. 31.
    Lafrance JP, Miller DR (2010) Acute kidney injury associates with increased long-term mortality. J Am Soc Nephrol 21:345–352CrossRefGoogle Scholar
  32. 32.
    Vanmassenhove J, Kielstein J, Jörres A, Van Biesen W (2017) Management of patients at risk of acute kidney injury. Lancet 389:2139–2151CrossRefGoogle Scholar
  33. 33.
    Nikolsky E, Mehran R, Turcot D, Aymong ED, Mintz GS, Lasic Z, Lansky AJ, Tsounias E, Moses JW, Stone GW, Leon MB, Dangas GD (2004) Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Am J Cardiol 94:300–305CrossRefGoogle Scholar
  34. 34.
    Stevens PE, Levin A (2014) Evaluation and Management of Chronic Kidney Disease : Synopsis of the Kidney Disease : Improving Global Outcomes 2012 Clinical Practice Guideline. Ann Intern Med 158:825–831CrossRefGoogle Scholar
  35. 35.
    Kinoshita M, Okayama H, Kosaki T, Hosokawa S, Kawamura G, Shigematsu T, Takahashi T, Kawada Y, Hiasa G, Yamada T, Matsuoka H, Kazatani Y (2018) Favorable effects of early tolvaptan administration in very elderly patients after repeat hospitalizations for acute decompensated heart failure. Heart Vessels 33:163–169CrossRefGoogle Scholar
  36. 36.
    Matsumoto K, Ehara S, Nakamura Y, Otsuka K, Kawase Y (2018) The effects of tolvaptan dose on cardiac mortality in patients with acute decompensated heart failure after hospital discharge. Heart Vessels 33:1204–1213CrossRefGoogle Scholar

Copyright information

© Springer Japan KK, part of Springer Nature 2018

Authors and Affiliations

  • Kenichiro Otsuka
    • 1
    Email author
  • Kenei Shimada
    • 2
  • Hisashi Katayama
    • 1
  • Haruo Nakamura
    • 1
  • Hirotoshi Ishikawa
    • 1
  • Hisateru Takeda
    • 1
  • Kohei Fujimoto
    • 1
  • Noriaki Kasayuki
    • 1
  • Minoru Yoshiyama
    • 3
  1. 1.Department of Cardiovascular MedicineIshikiri-Seiki HospitalHigashi-OsakaJapan
  2. 2.Department of Cardiovascular MedicineKashiba-Seiki HospitalKashibaJapan
  3. 3.Department of Cardiovascular MedicineOsaka City University Graduate School of MedicineOsakaJapan

Personalised recommendations